Treatment of anaplastic oligodendrogliomas: should resources be used to codify the old or to create the new?

A turning point in therapy followed the observation that patients with AO tumors with chromosome 1p and 19q codeletion had better outcomes when treated with irradiation and PCV than did non-codeleted anaplastic oligodendroglioma patients.